▽PharmaTimes World News ●04/27 23:23 Acoramidis approved for heart condition treatmentApr 25, 2025MHRA authorises drug for adults with rare heart muscle damageAll systems go!Apr 25, 2025Where to purchase reliable pharmacy automation systemsIntegrated Healthcare Manager Scotland/NI/WalesNetwork Manager - Norfolk & Waveney; Cambridgeshire and PeterboroughNetwork Manager - Mids and South Essex; SuffolkNetwork Manager - North Ea
▽Prescription Access Litigation (PAL) Project ●04/27 18:36 WARNING!prescriptionaccess.org has expired.If this is your domain name you must renew it immediately before it is deleted and permanently removed from your account. To renew this domain name visit NameBright.com
▽Food and Drug Administration--Press Releases ●04/27 18:12 http://www.fda.gov/ en http://www.fda.gov/news-events/press-announcements/hhs-fda-phase-out-petroleum-based-synthetic-dyes-nations-food-supply The U.S. Department of Health and Human Services and FDA today announced a series of new measures to phase out all petroleum-based synthetic dyes from the nation’s food supply—a significant milestone in the administration’s broader initiative to Make Americ
▽ Dept of Health - New publications ●04/27 13:07 AI doctors’ assistant to speed up appointments a ‘gamechanger’26 April 2025Press releaseChild death overview panels: contacts25 April 2025GuidanceAI doctors’ assistant to speed up appointments a ‘gamechanger’26 April 2025Press release